| Kayelyn J Wagner, MD | |
|
1600 W 22nd St, Sioux Falls, SD 57105-1521 | |
| (605) 312-1000 | |
| (605) 312-1001 |
| Full Name | Kayelyn J Wagner |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Hematology-oncology |
| Location | 1600 W 22nd St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043429087 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | 7508 (South Dakota) | Primary |
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | R-7702 (Iowa) | Secondary |
| Entity Name | Sanford Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396764254 PECOS PAC ID: 0244143824 Enrollment ID: O20031110000532 |
News Archive
The first advanced sensor assisted knee surgery in the world has been performed at Holy Cross Hospital in Fort Lauderdale, Fla. Through collaboration with OrthoSensor, Inc. in Fort Lauderdale, the new sensor technology is designed to improve patient recovery and overall implant function.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.
› Verified 6 days ago
| Entity Name | Sanford Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790721280 PECOS PAC ID: 6800707100 Enrollment ID: O20031111000266 |
News Archive
The first advanced sensor assisted knee surgery in the world has been performed at Holy Cross Hospital in Fort Lauderdale, Fla. Through collaboration with OrthoSensor, Inc. in Fort Lauderdale, the new sensor technology is designed to improve patient recovery and overall implant function.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.
› Verified 6 days ago
| Entity Name | Sanford Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821017880 PECOS PAC ID: 8325950215 Enrollment ID: O20040115000388 |
News Archive
The first advanced sensor assisted knee surgery in the world has been performed at Holy Cross Hospital in Fort Lauderdale, Fla. Through collaboration with OrthoSensor, Inc. in Fort Lauderdale, the new sensor technology is designed to improve patient recovery and overall implant function.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kayelyn J Wagner, MD Po Box 5074, Sioux Falls, SD 57117-5074 Ph: (605) 328-6585 | Kayelyn J Wagner, MD 1600 W 22nd St, Sioux Falls, SD 57105-1521 Ph: (605) 312-1000 |
News Archive
The first advanced sensor assisted knee surgery in the world has been performed at Holy Cross Hospital in Fort Lauderdale, Fla. Through collaboration with OrthoSensor, Inc. in Fort Lauderdale, the new sensor technology is designed to improve patient recovery and overall implant function.
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.
ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.
› Verified 6 days ago
Dr. Shari L Eich, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2100 S Marion Rd, Sioux Falls, SD 57106 Phone: 605-322-1010 Fax: 605-322-1011 | |
Michael Elliott, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 S 7th Ave, Ste 2, Sioux Falls, SD 57105 Phone: 605-336-2140 | |
Brock J Doubledee, D.O. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1600 W 22nd, Sioux Falls, SD 57105 Phone: 605-312-1000 Fax: 605-312-1001 | |
Katherine Wang, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-4425 Fax: 605-322-4499 | |
Gulsah Olgun, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1205 S Grange Ave Ste 307, Sioux Falls, SD 57105 Phone: 605-328-7800 Fax: 605-328-7899 | |
Mrs. Katie Elizabeth Larson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1205 S Grange Ave, Suite 307, Sioux Falls, SD 57105 Phone: 605-328-7800 Fax: 605-328-7899 |